GB1295276A - - Google Patents
Info
- Publication number
- GB1295276A GB1295276A GB1295276DA GB1295276A GB 1295276 A GB1295276 A GB 1295276A GB 1295276D A GB1295276D A GB 1295276DA GB 1295276 A GB1295276 A GB 1295276A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- prednisolone
- lithium succinate
- composition
- verdun
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 abstract 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
- 229940088710 antibiotic agent Drugs 0.000 abstract 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- WAHQBNXSPALNEA-UHFFFAOYSA-L lithium succinate Chemical compound [Li+].[Li+].[O-]C(=O)CCC([O-])=O WAHQBNXSPALNEA-UHFFFAOYSA-L 0.000 abstract 2
- 229960004254 lithium succinate Drugs 0.000 abstract 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
- VHRSUDSXCMQTMA-UWKORSIYSA-N 6-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1C(C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-UWKORSIYSA-N 0.000 abstract 1
- 108010001478 Bacitracin Proteins 0.000 abstract 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 abstract 1
- 108010040201 Polymyxins Proteins 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229960003071 bacitracin Drugs 0.000 abstract 1
- 229930184125 bacitracin Natural products 0.000 abstract 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 abstract 1
- 235000019445 benzyl alcohol Nutrition 0.000 abstract 1
- 239000003246 corticosteroid Substances 0.000 abstract 1
- 229960001334 corticosteroids Drugs 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
- 229940041616 menthol Drugs 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 229960005205 prednisolone Drugs 0.000 abstract 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 abstract 1
- 229960004618 prednisone Drugs 0.000 abstract 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- 229940040944 tetracyclines Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/12—Face or body powders for grooming, adorning or absorbing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5451669 | 1969-11-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1295276A true GB1295276A (enrdf_load_stackoverflow) | 1972-11-08 |
Family
ID=10471276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1295276D Expired GB1295276A (enrdf_load_stackoverflow) | 1969-11-06 | 1969-11-06 |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1295276A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999030675A1 (en) * | 1997-12-18 | 1999-06-24 | Johnson & Johnson Consumer Companies, Inc. | Methods for improving the health of hair and scalp |
-
1969
- 1969-11-06 GB GB1295276D patent/GB1295276A/en not_active Expired
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999030675A1 (en) * | 1997-12-18 | 1999-06-24 | Johnson & Johnson Consumer Companies, Inc. | Methods for improving the health of hair and scalp |
| US6099870A (en) * | 1997-12-18 | 2000-08-08 | Johnson & Johnson Consumer Companies, Inc. | Methods for improving the health of hair and scalp |
| RU2215518C2 (ru) * | 1997-12-18 | 2003-11-10 | Джонсон Энд Джонсон Конзьюмер Компаниз, Инк. | Способ увеличения количества анагенных волос, способ уменьшения выпадения волос, способ увеличения диаметра стержня волоса, способ увеличения густоты волос, способ увеличения времени роста волос |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1014469A (en) | Steroid formulation for topical application | |
| ES362679A1 (es) | Un procedimiento para la preparacion de nuevos esteroides anti-inflamatorios, de la serie del pregnano. | |
| GB1295276A (enrdf_load_stackoverflow) | ||
| CA920609A (en) | Anti-inflammatory agents | |
| AU472706B2 (en) | Anaesthetic steroid compositions | |
| AU4875472A (en) | 3 7-hydroxy-19-nor-5d-pregnane-11, 20-dione and pharmaceutical compositions thereof | |
| GB1199362A (en) | New Steroid Orthoesters and Process | |
| CA992980A (en) | .alpha.-AMINO-.beta.-(N-BENZYLTHIOCARBAMOYLTHIO) PROPIONIC ACID AND THERAPEUTIC COMPOSITIONS | |
| CA957280A (en) | Progestational composition in oral dosage form | |
| CA971105A (en) | VETERINARY COMPOSITIONS CONTAINING 6.alpha.,9.alpha.-DIFLUORO-16.alpha.-METHYLPREGNA-1,4-DIENE-11.beta.,17.alpha.,21-TRIOL-3,20-DIONE AND METHODS | |
| CA839229A (en) | Local anesthetic composition for topical application and process of making and using same | |
| GB1430223A (en) | Anti-inflammatory composition comprising steroids | |
| AU421766B2 (en) | New therapeutically active 3-or 1-oxo-dihydrobenszothiazines s-dioxides and process for their preparation | |
| ATSUMI et al. | Comparison of chromosomes in somatic cells and tumor cells of the white rat | |
| CA979363A (en) | Anti-inflammatory agents and process for their preparation | |
| IL36608A (en) | 16alpha,17alpha-dihydroxy-21-fluoro-pregna-4,6-diene-3,20-diones and derivatives thereof,their manufacture and pharmaceutical compositions containing them | |
| CA940536A (en) | Biphenyleneacetic acid anti-inflammatory agents | |
| AU1492670A (en) | New therapeutically active 3-or 1-oxo-dihydrobenszothiazines s-dioxides and process for their preparation | |
| CA613768A (en) | Topical analgesic compositions | |
| ES375060A1 (es) | Un procedimiento de preparacion de 21-esteres de la triam- cinolona y de la acetonida de triamcinolona. | |
| CA766749A (en) | 17-ESTERS OF 17.alpha.-HYDROXY-UNSATURATED-PREGNANE-3,20-DIONES | |
| CA739462A (en) | 3-keto unsaturated steroid compounds, compositions containing same and process for the preparation thereof | |
| CA880871A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 6-METHYL-16-METHYLENE-17.alpha.-HYDROXY-4,6-PREGNADIENE-3,20-DIONE 17-ACETATE | |
| CA859110A (en) | Pharmaceutical compositions containing 17-esters of 6-trifluoromethyl-14-hydroxyprogesterane | |
| AU422443B2 (en) | New therapeutically active substituted phenoxy-ethylamines and process for their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed |